From 5 November 2026 the Poisons and Therapeutic Goods Act and Regulation will be replaced by the:
This webpage outlines the requirements that will apply from 5 November 2026 onwards.
From 5 November 2026 the Medicines, Poisons and Therapeutic Goods Act 2022 and the Medicines, Poisons and Therapeutic Goods Regulation 2026 will introduce changes to the handling of medicines in healthcare settings.
This webpage provides health care settings a guide on changes that will apply to them and should be read in conjunction with the information for health practitioners.
Key changes include:
Private health facilities licensed under the Private Health Facilities Act 2007 may now obtain any Schedule 2, 3, 4, or 8 medicine.
The licensee of a private health facility must ensure that medication management policies and procedures are developed and implemented for the following:
Medication management policies and procedures must be approved by the medical advisory committee.
Private health facility policies and procedures must not be inconsistent with NSW Health Standards, including the Medicine Storage Standards, Vaccination Standards and OTP Standards.
[back to top]
Correctional centres must develop, implement and comply with policies and procedures for medication management, including access, storage and accountability.
The management company for a managed correctional centre must ensure policies and procedures are developed, implemented and maintained for the following:
Policies and procedures:
The new legislation introduces changes to the way patients are treated under the NSW Opioid Treatment Program (OTP). Providers of OTP services should familiarise themselves with the OTP legislative requirements.
[back to top]
[back to top]
The Act and Regulation outline penalties for offences associated with unauthorised activities.
Penalties are classified into 5 tiers and differ for individuals and corporations. They range from 20 to 400 penalty units for individuals and 100 to 2000 penalty units for corporations.
More information is available in the Act and Regulation. Further information on compliance notices and penalties will be published at a later date.
Supporting information to help understand the requirements of the legislation are available on the Pharmaceutical Services Medicines, Poisons and Therapeutic Goods legislation webpage.
The information on this webpage is provided for general guidance only. While reasonable care has been taken to ensure the accuracy, reliability, and currency of the information, users should refer to the Medicines, Poisons and Therapeutic Goods Act 2022 and the Medicines, Poisons and Therapeutic Goods Regulation 2026 for full and current legal requirements.